Miglitol, an oral alpha-glucosidase inhibitor similar to acarbase, is now available for treatment of type 2 diabetes....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to
The Medical Letter on Drugs and Therapeutics, please
login or
register to view it online.
If you have already purchased this article, or have a subscription to
The Medical Letter on Drugs and Therapeutics, please
login or
register to view it online.
Information about the article:
Title: Miglitol for Type 2 Diabetes Mellitus
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1053
Article Code: 1053b
Date: May 21, 1999
Volume: 41
Pages: 49-50